Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Montagna

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Blood|April 21, 2001
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemiaL Granziero, P Ghia, P Circosta, et al.
Blood|December 15, 1994
Abnormal expression of the p53-binding protein MDM2 in Hodgkin's diseaseM Chilosi, C Doglioni, F Menestrina, et al.
Pathologica|November 6, 2009
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's diseaseF Pedica, S Pecori, M Vergine, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 17, 2021
The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphyMatteo Bianco, A Parente, C Biolè, et al.
Multiple Sclerosis International|November 22, 2013
Growth hormone and disease severity in early stage of multiple sclerosisM Gironi, C Solaro, C Meazza, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 20, 2010
Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitisD Reghellin, V Poletti, S Tomassett, et al.
British Journal of Haematology|November 25, 2000
Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemiaM Chilosi, R Chiarle, M Lestani, et al.
Journal of Clinical Pharmacy and Therapeutics|August 3, 2006
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndromeG Derosa, A D'Angelo, P D Ragonesi, et al.
The Journal of International Medical Research|December 1, 2006
Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndromeG Derosa, A Dangelo, P D Ragonesi, et al.
Internal Medicine Journal|January 19, 2007
Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metforminG Derosa, A D'Angelo, P D Ragonesi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Blood|April 21, 2001
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemiaL Granziero, P Ghia, P Circosta, et al.
Blood|December 15, 1994
Abnormal expression of the p53-binding protein MDM2 in Hodgkin's diseaseM Chilosi, C Doglioni, F Menestrina, et al.
Pathologica|November 6, 2009
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's diseaseF Pedica, S Pecori, M Vergine, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 17, 2021
The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphyMatteo Bianco, A Parente, C Biolè, et al.
Multiple Sclerosis International|November 22, 2013
Growth hormone and disease severity in early stage of multiple sclerosisM Gironi, C Solaro, C Meazza, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|November 20, 2010
Cathepsin-K is a sensitive immunohistochemical marker for detection of micro-granulomas in hypersensitivity pneumonitisD Reghellin, V Poletti, S Tomassett, et al.
British Journal of Haematology|November 25, 2000
Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemiaM Chilosi, R Chiarle, M Lestani, et al.
Journal of Clinical Pharmacy and Therapeutics|August 3, 2006
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndromeG Derosa, A D'Angelo, P D Ragonesi, et al.
The Journal of International Medical Research|December 1, 2006
Effects of rosiglitazone and pioglitazone combined with metformin on the prothrombotic state of patients with type 2 diabetes mellitus and metabolic syndromeG Derosa, A Dangelo, P D Ragonesi, et al.
Internal Medicine Journal|January 19, 2007
Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metforminG Derosa, A D'Angelo, P D Ragonesi, et al.
Pageof 4